Fundraising FoxiGlobe Partners — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Accession Therapeutics develops cancer treatments by harnessing immune system mechanisms, with a focus on T cell receptor therapies and engineered cell therapies.
BiotechHealthtechMedical Devices
Alan Parker(CSO and Founder of Trocept)inBent Jakobsen(CEO and Founder)in
Co-investorsBirk Venture
Inkbit operates an additive manufacturing platform built on Vision-Controlled Jetting, which combines real-time 3D machine vision with closed-loop feedback and a custom material portfolio to produce dimensionally accurate, multi-material parts.
Advanced ManufacturingDeep TechHardwareNew MaterialsMedford, US
Davide Marini(Founder)inJavier Ramos(Co-founder & Chief Technology Officer)Wojciech Matusik(Co-Founder & Scientific Advisor)Steffi Kochbeck(VP Market Development)Guy Menchik(Director)Jason Weber(Director)
Co-investorsAlumni VenturesGC VenturesMassVenturesPhoenix Venture PartnersZeon Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.